The hiring of a law firm is an important decision that should not be based solely on advertisements. Before you decide, ask us to send you free written information about our qualifications and experience. Personal Injury Lawyers serving Daytona, Melbourne, Orlando, Florida and Nationwide.
The popular diabetes drugs Byetta and Januvia have been linked to an increased risk for life-threatening adverse side-effects, including pancreatic cancer. The U.S. Food and Drug Administration (FDA) is currently investigating a report that indicates these dangerous drugs can dramatically raise users’ risk for pancreatitis, a severe inflammation of the pancreas.
The Orlando-based injury attorneys at Colling Gilbert Wright & Carter are dedicated to helping victims of dangerous medications and medical devices nationwide. If you or a loved one suffered complications that may be associated with Byetta or Januvia, please call us at 855-880-4741 for your free case evaluation with one of our experienced lawyers.
Byetta, Januvia and Related Diabetes Drugs
Byetta and Januvia are part of the incretin mimetic class of drugs. Byetta is a brand name for exenatide, and it is an injectable medication marketed by Bristol-Myers Squibb and AstraZeneca; Januvia (sitagliptin) is a tablet produced by Merck.
In combination with positive changes in diet and exercise, incretin mimetic medications are intended to help adults with type 2 diabetes control their blood-sugar levels. According to the FDA, these drugs encourage the production of hormones that stimulate the release of insulin in response to meals.
Other commonly prescribed drugs in this class include Victoza (liraglutide), Bydureon (exenatide) and Janumet (sitagliptin). Mounting data, however, suggests incretin mimetic drugs like Byetta and Januvia can significantly increase patients’ risk for developing potentially fatal pancreatic conditions.
Byetta and Januvia Complications
The FDA previously issued a warning about a heightened risk of pancreatitis—both nonfatal and fatal instances—linked to Byetta, Januvia and other incretin mimetic drugs. The agency is now investigating one recent analysis of data that suggests these medications may increase a patient’s risk of pancreatitis sixfold.
There is also evidence of pre-cancerous cell changes in pancreatic tissue samples taken from patients using these drugs. The recently published findings of a study conducted by researchers with the University of California indicate a link between Byetta and Januvia and heightened risk for pancreatic cancer. The same study also noted a possible relation between Byetta and an increased risk for thyroid cancer.
The makers of Byetta and Januvia face a growing number of lawsuits filed on behalf of those who suffered severe, and in some cases deadly, adverse effects. These cases allege that the pharmaceutical makers in question failed to adequately warn patients of about the risks of their drugs.
If you or a family member was harmed due to Byetta or Januvia, you may be eligible to recover compensation for medical expenses and other damages. Please contact Colling Gilbert Wright & Carter today for your free consultation; our attorneys welcome clients from the greater Orlando area, across Florida and nationwide.